This document provides information on the management and complications of acute diarrhea. It discusses assessing patients with acute diarrhea by determining the type, examining for dehydration and complications, and assessing nutrition. It also covers taking a relevant history, examining the patient, assessing hydration status, laboratory investigations to identify the etiological organism, stool examination, and management including oral rehydration therapy. The management is based on rehydration, correcting electrolyte imbalance, ensuring adequate feeding and supplementation with zinc.
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
constipation in children , pediatric constipation , management of constipation in children , understanding constipation , causes of constipation in children , functional constipation in children , treatment of constipation ,approach to constipation in children ,constipation in infants
constipation in children , pediatric constipation , management of constipation in children , understanding constipation , causes of constipation in children , functional constipation in children , treatment of constipation ,approach to constipation in children ,constipation in infants
WHO and UNICEF recommended management of Childhood Diarrhoea.
HLFPPT has been implementing Childhood Diarrhea management programmes with UNICEF and Micronutrient Initiative.
Basics in Dehydration & it's management in paediatric practice. Prepared by Dr. Viduranga Edirisinghe on request by Prof. Wasantha Karunasekara. [2013 Aug]
A bunch of topic were selected for our subject Communicable Diseases, surprisingly I picked up "Cholera El tor"...
I have done enough research regarding this topic from Brunner and Suddarths MedSurg books and other resources. I collated the ideas and came up to this presentation...
Hope it will be able to help my colleagues, students and those people who needs to know the what, why's, and how of Cholera!
xoxo ^___^
It is a human toxic-infection caused by the presence in the intestine of vibrio cholerae. It is an acute infectious disease of the small intestine, caused by the bacterium vibrio cholera and characterized by profuse watery diarrhea, vomiting, muscle cramps, severe dehydration, and depletion of electrolytes. Vibrio cholerae is a Gram-negative, comma shaped rod, which is motile with a single terminal flagellum.
Vibrio cholera and Halophilic vibrio.pptDrmayuribhise
A 4-year-old boy developed severe watery diarrhea and vomiting. The stool collected has a rice water type of appearance. It was sent for bacteriological analysis.
a. What is the probable etiological diagnosis of this condition?
b. Describe in detail the pathogenesis of this condition.
c. Add a note on its laboratory diagnosis.
Which of the following media can be used as transport medium for vibrio?
a. Selenite F broth
b. Nutrient broth
c. Tetrathionate broth
d. Venkatraman–Ramakrishnan medium
All of the following tests can differentiate between classical and El Tor biotypes of V. cholerae, except:
a. β-hemolysis on sheep blood agar
b. Chick erythrocyte agglutination
c. Growth on TCBS agar
d. Polymyxin B (50 IU)
Pathogenesis of V. cholerae involves one of the following second messenger systems:
a. cGMP
b. cAMP
c. Ca2+
d. IP3
Selective media for Vibrio cholerae:
a. TCBS
b. Mannitol salt agar
c. Robertson cooked meat medium
d. Modified Thayer Martin medium
All of the following Vibrio species are halophilic, except:
a. V. cholerae
b. V. parahaemolyticus
c. V. alginolyticus
d. V. vulnificus
O139 (Bengal strain)—all are true, except:
a. Capsulated
b. Toxigenic
c. Clinically similar to El Tor
d. More common than El Tor
All are selective media for V. cholerae, except:
Alkaline peptone water
Alkaline bile salt agar
TCBS agar
Monsur’s agar (GTTTA) medium
Which of the following confirms the isolate of V. cholerae as Hikojima serotype?
a. If agglutinated with Ogawa antisera
b. If agglutinated with Inaba antisera
c. If agglutinated with Hikojima antisera
d. If agglutinated with both Ogawa and Inaba antisera
Gram negative
Rigid, curved rods
“Vibrio” – vibratory motility
Non - sporing
Non - capsulated
Present in marine environments & surface waters worldwide
1854 – observed by Pacini
1883 – first isolated by Koch
Vibrio cholerae Top
V. cholerae was first described as the cause of cholera by Pacini in 1854. Pathogenic V. cholerae
produces a heat-sensitive enterotoxin that causes the characteristic cholera symptoms, including
"rice water stool." The species comprises several somatic (O) antigen groups, including O-group1, which is associated with classical and El Tor biotypes. V. cholerae Ol may have several
serotypes, including Inaba, Ogawa, and Hikojima. V. cholerae non-O1 (referred to in older
literature as nonagglutinable or NAG vibrios) also can cause gastrointestinal disease, though
typically less severe than that caused by V. cholerae O1 (Yamamoto et al., 1983). Serotype O139
is an exception, and produces classic cholera symptoms. This serotype was first identified in
1992 (CWG, 1933) as the cause of a new epidemic of cholera in India and Bangladesh. Non-O1
V. cholerae is found more readily in estuarin! e waters and seafood in the United States than is
the Ol serogroup; however, the 0139 serogroup has not yet been found here. Because this species
can grow in media lacking sodium chloride, it is not considered a halophilic Vibr
Cholera is a acute diarrhoeal disease caused by Vibrio cholerae.
Majority of infection are mild or asymptomatic.
IV B.PHARM, 8-SEMESTER ,SOCIAL AND PREVENTIVE PHARMACY.
CHOLERA DISESASE
DEFINITION, SYMPTOMS, CAUSES, TREATMENT, PREVENTION.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
2. ASSESSMENT OF CHILD WITH
ACUTE DIARRHEA :
The evaluation of a child with acute diarrhea
aims at following :-
i. To determine the type of diarrhea i.e.
acute watery diarrhea(secretory),
dysentry(invasive),
osmotic diarrhea, or
persistent diarrhea.
ii. To look for the degree of dehydrtion and
associated complications.
3. iii. Assessment of nutritional status and
feeding practices ,both preillness and
during illness.
iv. Obtain appropriate contact or exposure
history and rule out non- diarrheal
illnesses especially systemic infections.
4. HISTORY - TAKING RELEVANT TO
DIARRHEA :
History should include following informations :
i. Onset of diarrhea, duration and no. of
stools per day.
ii. Blood in stools.
iii. No. of episodes of vomiting.
iv. Presence of fever, cough, or other
significant symptoms like convulsions
,recent measles.
v. Exposure or contact history i.e.
information about exposure to contacts
with similar symptoms, intake of
5. water, recent travel to a diarrhea-endemic
area.
vi. Type and amount of fluids (including
breast milk) and food taken during the
illness and preillness periods.
vii. Use of anti-microbial agents ,other drugs
or any local remedies (if taken).
vii. Immunization history
6. EXAMINATION OF THE PATIENT :
For prompt treatment, assessment of the
hydration status of child is most important.
In addition to it, following points must also be
examined :
a. Features of malnutrition i.e. anthropometry for
wt. and ht. , examination for wasting, edema
and signs of vitamin deficiency.
b. Features of systemic infections i.e. presence
of cough, high grade fever, fast breathing
and/or chest indrawing suggests pneumonia,
high grade fever with splenomegaly suggests
malaria.
7. c. Signs of fungal infections like oral thrush
or perianal satellite lesions.
8. Hydration status can be assessed as
follows :
I.Clinical
signs :
General
conition
Well-alert Fatigued,
restless,
irritable
Apathetic,
lethargic,
unconsciou
s
Eyes normal Slightly
sunken
Deeply
sunken
Thirst Drinks
normally,
might refuse
fluids
Thirsty
,eager to
drink
Drinks
poorly,
unable to
drink
9. Tears +nt decrease
d
-nt
Mouth
and
tongue
moist dry Very dry
Heart rate normal Normal to
increased
tachycardia;
with
bradycardia
in more
severe
cases
breathing Normal Normal,
fast
deep
Quality of normal decrease Weak,
thready or
10. Skinfold Instant
recoil
Recoil in
<2 sec.
Recoil in >
2 sec.
Capillary
refilling
time
normal prolonged Minimal
refilling
extremitie
s
warm cold Cold,
mottled,
cyanotic
Urine
output
Normal to
decreased
decreased minimal
11. Hydrati-
on
status :
The patient
has NO
signs of
dehydration.
If the pt.has
2 or more
signs, there
is SOME
dehydration
If the pt.has
2 or more
signs, there
is SEVERE
dehydration
Treatme
-nt plan
:
Use t/t
Plan `A`
Weigh the
pt. , use t/t
Plan `B`
Weigh the
pt. , use t/t
Plan `C`.
12. ASSESSMENT OF AMOUNT OF FLUID
LOSS :
Degree of
dehydration
Fluid loss
NO Dehydration <50ml/kg
(<3% loss of body wt.)
SOME Dehydration 50-100ml/kg
(3-9% loss of body wt.)
SEVERE Dehydration >100ml/kg
(>9% loss of body wt.)
13. Laboratory investigations :
The large majority of acute diarrheal
episodes can be managed effectively
in absence of lab investigations .
If warranted and if facilities and
resources permit, the underlying
etiology can be verified by appropriate
lab testings.
The various methods of lab
investigations for confirming the
suspected etiological organisms
15. Contd. :-
Etiology(
bacteria)
S/S Duration
of illness
Lab
testing
Enterotoxige
nic
E.coli(ETEC
)
Watery
diarrhea,
abdominal
cramps,
some
vomiting
3 to >7 days Stool culture
and
identification
requires
special lab
tech.
Salmonella Diarrhea,fev
er,
abdominal
cramps,
vomiting
4-7 days Routine
stool
cultures
16. Contd. :-
etiology S/S Duration
of illness
Lab
testing
Shigella spp. Abdominal
cramps, fever
and diarrhea.
Stool may
contain blood
and mucus.
4-7 days Routine stool
cultures
Staphylococc
us aureus
(preformed
toxin)
Sudden onset
of severe
nausea,
vomiting ,
diarrhea and
fever may be
present
24-48 hrs. Mainly clinical
diagnosis. If
indicated,
stool, vomitus
and food
tested for
toxin.
17. etiology S/S Duration
of illness
Lab
testing
Vibrio cholerae
(toxin)
Profuse watery
diarrhea and
vomiting; may
lead to severe
dehydration
and death
within few hrs.
3-7 days ,
causes life-
threatening
dehydration
Stool culture. If
suspected
requires
special
medium for
growth.
Vibrio
parahemolyticu
s
Watery
diarrhea,
abdominal
cramps,
nausea,
vomiting
2-5 days Stool culture
and specific
testing
18. Etiology
(viral)
S/S Duration
of illness
Lab
testing
Rotavirus Vomiting, watery
diarrhea, low-
grade fever.
Temporary
lactose
intolerance may
occur.
4-8 days Immunoassay
for identification
of viruses in
stool
Noroviruses(
and other
caliciviruses)
Nausea,
vomiting,
abdominal
cramping,
diarrhea, fever,
myalgia and
headache.
12-60 hrs. Routine RT-PCR
and EM on fresh
unpreserved
stool. Clinical
diagnosis,
negative bact.
cultures, WBCs
absent.
19. Etiology(p
arasitic)
S/S Duration
of illness
Lab
testing
Giardia lamblia diarrhea.,
stomach cramps,
gas, wt.loss
Days to wks. Stool
examination for
ova and
parasites -
atleast 3
samples
Entamoeba
histolytica
Diarrhea (often
bloody), frequent
bowel
movements,
lower abdominal
pain
Several wks. To
mnths.
Stool examn. For
cysts and
parasites.
Serology for
long- term infns.
Cryptosporidium Diarrhea( usually
watery ),
stomach cramps,
upset stomach
May be remitting
ans relapsing
over wks. To
mnths.
Specific
examination for
Cryptosporidium.
Also examine
water and food.
20. STOOL EXAMINATION :
Microscopic examination and culture of stool
is most routinely practiced to know the
cause of diarrhea.
Stool specimens or rectal swabs should be
collected from children with acute diarhea in
following cases :
i. watery diarrhea (suspected cholera)
ii. Bloody diarrhea (dysentry)
iii. Malnourished and immuno-compromised children
iv. In outbreaks with suspected HUS.
21. Stool specimens are examined for mucus, blood
& leucocytes.
Fecal leucocytes are indicative of bacterial
invasion of gut mucusa.
In endemic areas, stool microscopy must include
examination for parasites causing diarrhea
such as G.lamblia and E.histolytica .
Stool specimens for culture need to be
transported and plated quickly; if latter is not
available , specimens may need to be
transported in special media k/a TRANSPORT
MEDIA.
22. TRANSPORT MEDIA :
Cary Blair transport medium -
can be used to transport Shigella , V. cholerae ,
E.coliO157:H7.
because of high ph (8.4), it is the medium of
choice for V. cholerae .
Amie’s and Stuart’s media -
both are acceptable for Shigella and E. coli
O157:H7 ; but they are inferior to Cary Blair
medium for transport of V. cholerae.
Buffered Glycerol Saline (BGS) -
used for Shigella, but is unsuitable for V.
cholerae .
23. NOTE : In most previously healthy children
with uncomplicated watery diarrhea, no
laboratory evaluation is needed for
epidemiologic purposes.
If diarrhea is associated with findings
indicative of complications such as pallor,
labored breathing, altered sensorium,
seizures, paralytic ileus or oliguria ,
additional laboratory investigations need
to be performed. They are :-
i. Stool ph
ii. Complete hemogram
iii. Blood gas estimation
iv. Serum electrolytes
v. Renal function tests , etc..
24. MANAGEMENT OF A CHILD WITH
ACUTE DIARRHEA :
It is based on following basic principles :
a) Rehydration and maintaining hydration.
b) Correction of electrolyte and acid-base
imbalance.
c) Ensuring adequate feeding.
d) Oral supplementation of Zinc.
e) Early recognition of danger signs and t/t of
complications.
f) Nutritional rehabilitation.
g) Health education for prevention of diarrhea.
25. ORAL REHYDRATION THERAPY
(ORT)
With the discovery of glucose-dependent
sodium pump in the small bowel, which
results in passive absorptin of water and
other electrolytes , the concept of
rehydration has been revolutionaized.
The glucose- dependent sodium and water
absorption is the principle behind replacing
glucose and sodium in 1:1 molar ratio in
WHO-ORS for optimum absorption.
26. NOTE : While making ORT, the
osmolarity of the replacement fluid
should not exceed that of blood (290
mmol/L) ; for maintenance of
concentration gradient b/w intestinal
lumen and blood stream to allow
greater absorption of fluids into blood.
27. ORAL REHYDRATION SALTS (ORS)
SOLUTION :
Home - made or commercially available salt
and sugar solutions for rehydration are k/a
oral rehydration salts (ORS) solutions.
Optimum absorption of glucose takes place
from the intestines b/w a glucose
concentration of 111-165 mmol/L and
sodium :glucose ratio b/w 1: 1 to 1:1.4 .
Moreover, meta-analysis have shown that
use of Low- osmolarity ORS has many
advantages over standard WHO-ORS
(osml. = 311mmol/L).
28. Since 2004, based on the WHO- UNICEF
and IAP recommendations, the Govt. of
India has adopted the Low- osmolarity ORS
(osml. = 245 mmol/L) as the single
universal ORS to be used for al ages and
all types of diarrhea.
Advantages of Low-osmolarity ORS are :
a. Reduction in stool output.
b. Decrease in vomiting.
c. Decrease in use of unscheduled i.v. fluids.
d. Decreased risk of hypernatremia.
29. COMPOSITION & CONCENTRATION OF
STANDARD WHO-ORS :
Ingredients Compositio
n (gms./L)
Ingredients Concentrat
ion
(mmol/L)
Sodium
chloride
3.5 Sodium 90
Potassium
chloride
1.5 Potassium 80
Trisodium
citrate (anhyd.)
2.9 Citrate 10
Glucose
(anhyd.)
20 Glucose 111
Osmolarity
=
311
31. Home- available fluids for acute diarrhea ( can
be used if ORS formulations not available) :
Fluids that contain salt
(preferable)
Salted drinks (e.g. salted rice
water or salted yoghurt drink),
vegetable or chicken soup with
salt.
Fluids that donot contain salt
(acceptable)
Plain water, unsalted rice
water, unsalted soup, yoghurt
without salt, green coconut
water, weak unsweetened tea,
fresh fruit juice .
Unsuitable home available
fluids
Commercial carbonated
beverages, commercial fruit
juices, sweetened tea.
32. Treatment Plan ‘A’ : for ‘NO’ dehydration
The objective of Plan ‘A’ is prevention of
dehydration and malnutrition.
The management can be successfully carried out
at home , by the mother / caretaker who is
advised to :
i. WHO-ORS or other ORT fluids are to be given as per
advise;
ii. Continue feeding; and
iii. Bring the child back after 2 days, or earlier if he has
any of the danger signs (increased volume or
frequency of stools, repeated vomiting, increasing
thirst, irritable/restless, fever, blood in stool, refusal to
feed, lethargic ).
33. ORT as per Plan ‘A’ :
Age Amt. of ORS/ORT
fluids to be given
after each loose
stool
Total amount of
ORS to provide for
use at home
< 24 months 50-100 ml 500ml/day
2-10 yrs. 100-200 ml 1000ml/day
> 10 yrs. As much as child
can take
2000ml/day
NOTE :
-A teaspoonful is given every 1-2 min. for a child <2yrs.
-Frequent sips from a cup are given for older children.
-Following vomiting, wait for 10 mins.and give ORS more slowly.
-If danger signs appear or diarrhea continues, consult doctor.
34. Treatment Plan ‘B’ : for ‘SOME’
dehydration
The objective of Plan ‘B’ ia to treat
dehydration and electrolyte imbalance; and
to continue feeding.
These cases need to be treated in a health
center or hospital.
While transporting, ORT must be promptly
started and continued.
Fluid requirement is calculated as per :
i) Normal daily fluid requirement (+)
ii) Deficit replacement or rehydration therapy (+)
iii) Maintenance fluid therapy to compensate losses .
35. i. Daily fluid requirement :- It is calculated as
follows -
- upto 10 kg = 100ml/kg
- 10-20 kg = 50ml/kg
- >20 kg = 20ml/kg
ii. Deficit fluid or rehydration therapy :- It is calculated as
75ml/kg of ORS , to be given over 4 hrs.. If ORS cannot
be taken orally then nasogastric tube can be used.
If after 4 hrs. , child still has some dehydration then
another t/t of ORS is to be given. This is effective in
95% cases.
For infants<6mo.who are not breastfed, along with
WHO-ORS 100-200 ml plain water must be given in
addition. Breast -feeding must be encouraged.
When body wt. is not known , amount of ORS required
can be calculated according to age as follows :
36. Fluid calculation acc.to age as per Plan ‘B’ :-
Age <4m
o.
4-
11m
o.
12-
23m
o.
2-
4yr.
5-
14yr.
>=
15yr.
weight <5kg 5-8kg 8-
11kg
11-
16kg
16-
20kg
>30kg
ORS,
ml
200-
400
400-
600
600-
800
800-
1200
1200-
2200
>2200
No. of
glasse
s
1-2 2-3 3-4 4-6 6-11 12-30
37. iii. Maintenance fluid therapy :- If patient
becomes rehydrated i.e. signs of
dehydration disappear, continue treatment
with ORS as per Plan ‘A’ for NO
dehydration.
Breastfeeding and semi-solid food should
be continued and plain water can be
offered in between.
If ORT is not successful, treat as SEVERE
dehydration with i.v. fluids as per Plan ‘C’ .
38. Treatment Plan ‘C’ : for ‘SEVERE’
dehydration
The primary objective of Plan ‘C’ is to quickly
rehydrate the child in a hospital with
facilities for I.V. fluid therapy .
Ringer’s lactate with 5% dextrose is the
preferred solution for rehydration . Normal
saline or plain Ringer solution may be used
as an alternative ,but 5% dextrose alone is
not effective.
A total of 100ml/kg of fluid is given ,over
6hr.in children < 12months and over 3hr.in
children >12 months . ORS solution be
started simultaneously if the child can take
orally.
39. If i.v. fluids cannot be given , nasogastric
feeding is given at 20ml/kg/hr. for 6hr. (total
120ml/kg) .
The child should be reassessed every 1-2 hr;
if there is repeated vomiting or abdominal
distension , the oral or nasogastric fluids are
given more slowly . If there is no
improvement in hydration after 3hr. , IV fluids
should be started at the earliest.
MONITORING :
Assess for improvement every 1-2 hr. :-
- If not improving, give IV infusion more rapidly.
- Encourage oral feeding by giving ORS 5ml/kg/hr,
along with IV fluids ,as soon as child is able to take.
40. Reassess hydration status :-
- The child should be reassessed every 15-30 min.
for pulses and hydration status after the first bolus
of 100ml/kg of IV fluid.
- The child should be observed for atleast 6 hr.
before discharge, to confirm that the mother is able
to maintain the child’s hydration by giving ORS
solution.
- It is recommended that severely malnourished
children should be slowly rehydrated, carefully
monitored and feeding to be started early.
- Infants below 2 months of age must be carefully
monitored as they are prone to septicemia and
severe electrolyte imbalance.
41. ZINC SUPPLEMENTATION :
Zinc supplementation is now part of the standard
care along with ORS in children with acute
diarrhea.
Zinc deficiency and intestinal losses during
diarrhea aggravate the deficit .
Zinc is helpful in decreasing severity and
duration of diarrhea and also the risk of
persistence.
DOSE : Zinc is recommemded to be
supplemented as sulphate , acetate or
gluconate formulations ; at a dose of 10mg of
elemental Zn per day for children< 6mo. &
20mg per day for >6mo. For a period of 14
days.
42. FEEDING DURING DIARRHEA :
Recommended
schedule of feeding
Breastfed infants Continue breastfeeding
non-breastfed infants Shld .be preferably given
only ORS till they are
rehydrated.
Animal milk/food sld.be
offered .
Severely malnourished
children
As soon as possible , food
should be offered i.e.
energy-giving foods .
During rehydration phase -
43. After rehydration phase -
Recommended feeding
Breastfed infants Breastfeed more frequently
non-breastfed infants Offer undiluted milk as before
Infants (6-12 months) Give easily digestible energy-
rich complementary foods in
addition to breast/animal milk.
Encourage to increase
frequency of feeding.
Older children Staple foods enriched with
fat,oil and sugar. Fruits like
banana ,legumes (rich in K ).
Vit. A rich foods.
Encourage to eat atleast 6
times a day.
44. ANTI-MICROBIAL THERAPY :
Causes Drugs of
choice
Doses
Cholera Doxycycline or
Furazolidone or
Trimethoprim -
sulfamethoxazol
e
Single dose of
5mg/kg (max. =
200 mg)
5-8mg/kg/day in
4 divided doses
* 3 days
TMP 10mg/kg
and SMX
50mg/kg in 2
divided doses *3
days
45. Causes D.O.C. Doses
Dysentery TMP + SMX or
Nalidixic acid or
Ciprofloxacin
(resistant-cases)
TMP 10mg/kg and
SMX 50mg/kg in 2
divided doses * 5
days
60mg/kg/day in 4
divided doses *
5days
Amoebic dysentery Metronidazole 30mg/kg/day in 3
divided doses * 5-10
doses
Acute giardiasis Metronidazole or
Tinidazole
15mg/kg/day in 3
divided doses *5
days
10-15 mg/kg/day in 3
divided doses * 5
days
46. ADDITIONAL DRUG THERAPY FOR
ASSOCIATED SYMPTOMS :
Severe or recurrent vomiting - single dose of
Ondansetron (0.1-0.2 mg/kg/dose ) can be given.
Abdominal distension - no specific treatment
required.
Paralytic ileus - (if bowel sounds absent ) may
occur d/t hypokalemia, antimotility drugs or
septicemia ; oral intake should be stopped.
Hypokalemia with paralytic ileus - IV fluids only and
nasogastric aspiration , along with KCl (30-
40mEq/L) I.V. ; provided child is passing urine.
Convulsions - to be treated as per the underlying
etiology.
47. PREVENTION OF DIARRHEA AND
MALNUTRITION :
The three important measures are :
1. Improving infant feeding practices and
personal and domestic hygiene which
includes:
• Promotion of exclusive breast-feeding
upto 6 months of age.
• Improved complementary feeding
practices.
• Use of clean drinking water .
• Three Cs : clean hands,clean container
and clean envt..
• Adequate sewage disposal system and
48. II. Proper nutrition and care of mother as well
as child during the antenatal, natal and
post-natal periods. Adequate awareness
of the mother about symptoms of diseases
and vigilance to consult doctor .
III. Vaccination : Recent studies have
demonstrated safety and efficacy of RVV
(RotaVirus Vaccine) and thereby
suggesting a combined preventive and t/t
strategy ( vaccine, ORS and Zn
supplements) to reduce child mortality d/t
diarrhea. RVV has been scheduled as
routine vaccine as per IAP
recommendation at 6, 10 and 14 wks.of
age.
49. COMPLICATIONS OF ACUTE
DIARRHEA :
Majority of the ccomplications associated with
diarrhea are related to delays in diagnosis
and early institution of prompt treatment.
Without early and appropriate rehydration
,children may develop complications ; which
can be life- threatening.
Inappropriate t/t can lead to prolongation of
episode of illness , consequent malnutrition
, secondary infections and micronutrient
deficiencies.
50. Thus , various complications associated
with diarrhea can be listed as follows :
1. Persistent diarrhea
2. Malnutrition
3. Vitamins and mineral deficiencies
4. Hypoglycemia resulting in convulsions
and permanent brain damage.
5. Hypo- or hyper- natremic seizures
6. Focal infections d/t systemic spread of
pathogens like UTI, endocarditis,
pneumonia, meningitis, osteomyelitis,
encephalitis, etc..
51. 7. Reactive arthritis
8. Glomerulonephritis and IgA
nephropathy
9. Hemolytic Uremic Syndrome (sudden
onset ,short - term renal failure )
10. Heart failure due to severe electrolyte
imbalances .